Direct Oral Anticoagulants in Patients with Diabetes and Nonvalvular Atrial Fibrillation
Diabetes mellitus (DM) is a common comorbidity in patients with atrial fibrillation (AF) and is associated with an increased frequency of major adverse cardiac...
Active Screening for Atrial Fibrillation to Protect Against Strokes and Other Events
Seeking to answer if screening asymptomatic individuals for atrial fibrillation (AF) could offer meaningful protection against strokes and other clinical outcomes, Steven Steinhubl, MD,...
Final Results from REPRISE III: Long-Term Stroke Risk after TAVR for Severe Aortic Stenosis
A study presented at the Transcatheter Cardiovascular Therapeutics (TCT) 2021 Annual Meeting reported the final five-year results from the REPRISE III randomized trial, which...
Smoking Linked to Fatal Event as First Sign of CVD
Middle-aged women and men who smoke have an increased risk for having a fatal cardiovascular disease (CVD) event as their first sign of CVD,...
Cardio Round-Up: Assessing Dose-Response Between PAD and Physical Activity; and More
VTE Patients have a Risk of Major Bleeding Once Anticoagulants are Discontinued
Currently, the long-term risk of major bleeding after discontinuing anticoagulant therapy for a...
Diabetes Patients Less Often Perceive Atrial Fibrillation Symptoms
Patients with atrial fibrillation (AF) who have diabetes less often perceive AF symptoms, although they are more likely to have cardiac and neurologic comorbidities,...
Cardio Round-Up: 40% of Middle Age Adults Have Fatty Hearts; and More
4 Out of 10 Adults With No Known Heart Disease Have Fatty Hearts: Study
Many middle-aged adults with apparently healthy hearts have a "silent" buildup...
